Calcific aortic valve stenosis: potentials and complications of surgical treatment

Abstract

Aim. The study aim is to discuss different approaches to the selection of a method of surgical correction of pronounced aortic stenosis (AS). Indications, contraindications, advantages and probable complications of transcatheter aortic valve implantation (TAVI) are considered. A description of a clinical case is given, and probable causes of unfavorable outcomes are discussed.

AS is the most common valvular disease, and its frequency increases significantly with age. It is one of the leading indications for heart surgery. A peculiarity of the clinical presentation of AS is a long asymptomatic period that varies from patient to patient. With the appearance of the first clinical manifestations, the prognosis of the disease sharply worsens. For a long time, surgical replacement of the aortic valve remained «the gold standard» of treatment of patients with symptomatic AS. An increase in the number of elderly patients and those in old age with many comorbid diseases who have received cardiopulmonary bypass is linked with an increased risk of postoperative complications, which are became a determining factor for the development of alternative methods of surgical correction of aortic valve pathology.

Conclusion. At present, TAVI has considerable advantages over surgical replacement; is a method of choice for elderly and inoperable patients as well as patients at high, intermediate, and low risk from surgery; and requires a multidisciplinary approach.

Keywords

aortic stenosis / transcatheter replacement aortic valve / advantages / complications

References

[1] Lung B, Delgado V, Rosenhek R, et al. Contemporary Presentation and Management of Valvular Heart Disease The EURObservational Research Programme Valvular Heart Disease II Survey. Circulation. 2019;140(14):1156-69. doi:10.1161/CIRCULATIONAHA.119.041080

[2] Lung B., Delgado V., Rosenhek R., et al. Contemporary Presentation and Management of Valvular Heart Disease The EURObservational Research Programme Valvular Heart Disease II Survey // Circulation. 2019. Vol. 140, №14. Р. 1156-1169. doi:10.1161/CIRCULATIONAHA.119.041080

[3] Aisling K, Annamalar M, Cusimano RJ, et al. Aortic Stenosis: Causes and Management. Journal of Cardiology & Cardiovascular Therapy. 2018;12 (1):555827. doi:10.19080/JOCCT.2018.12.555827

[4] Aisling K., Annamalar M., Cusimano R.J., et al. Aortic Stenosis: Causes and Management // Journal of Cardiology & Cardiovascular Therapy. 2018. Vol. 12, №1. P 555827. doi:10.19080/JOCCT. 2018.12.555827

[5] Akahori H, Tsujino T, Masuyama T, et al. Mechanisms of aortic stenosis. Journal of Cardiology. 2018;71(3):215-220. doi:10.1016/j.jjcc.2017.11.007

[6] Akahori H., Tsujino T., Masuyama T., et al. Mechanisms of aortic stenosis // Journal of Cardiology. 2018. Vol. 71, №3. P. 215-220. doi:10.1016/j.jjcc. 2017.11.007

[7] Dweck MR, Boon NA, Newby DE. Calcific aortic stenosis: a disease of the valve and the myocardium. Journal of the American College of Cardiology. 2012;60(19):1854-63. doi:10.1016/j.jacc.2012.02.093

[8] Dweck M.R., Boon N.A., Newby D.E. Calcific aortic stenosis: a disease of the valve and the

[9] Petrov VS, Zhdanov AI, Smirnova EA. Influence of aortal stenosis on manifestations of chronic rheumatic heart disease. Nauka Molodykh (Erudi-tio Juvenium). 2019;7(4):493-500. (In Russ). doi:10. 23888/HMJ201974493-500

[10] myocardium // Journal of the American College of Cardiology. 2012. Vol. 60, №19. P. 1854-1863. doi:10.1016/j.jacc.2012.02.093

[11] Baumgartner H, Falk V, Bax JJ, et al. ESC/EACTS Guidelines for the management of valvular heart disease. European Heart Journal. 2017;38(36): 2739-91. doi:10.1093/eurheartj/ehx391

[12] Петров В.С., Жданов А.И., Смирнова Е.А. Влияние аортального стеноза на проявления хронической ревматической болезни сердца // Наука молодых (Eruditio Juvenium). 2019. Т. 7, №4. С. 493-500. doi:10.23888/HMJ201974493-500

[13] Baumgartner H, Hung J, Bermejo J, et al. Recommendations on the Echocardiographic Assessment of Aortic Valve Stenosis: A Focused Update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Journal of the American Society of Echocardiography. 2017;30(4):372-92. doi:10.1016/j.echo.2017.02.009

[14] Baumgartner H., Falk V., Bax J.J., et al. ESC/ EACTS Guidelines for the management of valvular heart disease // European Heart Journal. 2017. Vol. 38, №36. P. 2739-2791. doi:10.1093/eurheartj/ehx391

[15] Harken DE, Soroff HS, Taylor WJ, et al. Partial and complete prostheses in aortic insufficiency. The Journal of Thoracic and Cardiovascular Surgery. 1960; 40(6):744-62. doi:10.1016/S0022-5223(19)32572-3

[16] Baumgartner H., Hung J., Bermejo J., et al. Recommendations on the Echocardiographic Assessment of Aortic Valve Stenosis: A Focused Update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography // Journal of the American Society of Echocardiography. 2017. Vol. 30, №4. P. 372-392. doi:10.1016/j.echo.2017.02.009

[17] Sokolov VV, Parkhomenko MV, Kovalyov AI, et al. Comparative evaluation of aortic valve replacement methods in patients over 70 with aortic stenosis. Russian Sklifosovsky Journal of Emergency Medical Care. 2018;7(3):227-33. (In Russ). doi:10.23934/ 2223-9022-2018-7-3-227-233

[18] Harken D.E., Soroff H.S., Taylor W.J., et al. Partial and complete prostheses in aortic insufficiency // The Journal of Thoracic and Cardiovascular Surgery. 1960. Vol. 40, №6. P. 744-762. doi:10.1016/ S0022-5223(19)32572-3

[19] Borger MA, Moustafine V, Conradi L, et al. A randomized multicenter trial of minimally invasive rapid deployment versus conventional full sternotomy aortic valve replacement. The Annals of Thoracic Surgery. 2015;99(1):17-25. doi:10.1016/j. athoracsur.2014.09.022

[20] Соколов В.В., Пархоменко М.В., Ковалёв А.И., и др. Сравнительная оценка методов протезирования аортального клапана у больных старше 70 лет с аортальным стенозом // Неотложная медицинская помощь. Журнал им. Н.В. Склифосовского. 2018. Т. 7, №3. С. 227-233. doi:10.23934/ 2223-9022-2018-7-3-227-233

[21] Gilmanov D, Miceli A, Ferrarini M, et al. Aortic Valve Replacement Through Right Anterior Minithoracotomy: Can Sutureless Technology Improve Clinical Outcomes? The Annals of Thoracic Surgery. 2014;98(5):1585-92. doi:10.1016/j.athoracsur. 2014.05.092

[22] Borger M.A., Moustafine V., Conradi L., et al. A randomized multicenter trial of minimally invasive rapid deployment versus conventional full sternotomy aortic valve replacement // The Annals of Thoracic Surgery. 2015. Vol. 99, №1. P. 17-25. doi:10.1016/j.athoracsur.2014.09.022

[23] Phan K, Tsai Y-C, Niranjan N, et al. Sutureless aortic valve replacement: a systematic review and metaanalysis. Annals of Cardiothoracic Surgery. 2014; 4(2):100-11. doi:10.3978/j.issn.2225319X.2014.06.01

[24] Gilmanov D., Miceli A., Ferrarini M., et al. Aortic Valve Replacement Through Right Anterior Minithoracotomy: Can Sutureless Technology Improve Clinical Outcomes? // The Annals of Thoracic Surgery. 2014. Vol. 98, №5. P. 1585-1592. doi:10. 1016/j.athoracsur.2014.05.092

[25] Cribier A, Savin T, Saoudi N, et al. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet. 1986;326(8472):63-7. doi:10.1016/ S0140-6736(86)90716-6

[26] Phan K., Tsai Y.-C., Niranjan N., et al. Sutureless aortic valve replacement: a systematic review and meta-analysis // Annals of Cardiothoracic Surgery. 2014. Vol. 4, №2. P. 100-111. doi:10.3978/j.issn. 2225319X.2014.06.01

[27] Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. European Heart Journal. 1992;13(5):704-8. doi:10.1093/oxfordjournals. eurheartj.a060238

[28] Cribier A., Savin T., Saoudi N., et al. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? // Lancet. 1986. Vol. 326, №8472. P. 63-67. doi:10.1016/S0140-6736(86)90716-6

[29] Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106(24):3006­8. doi:10.1161/01.CIR.0000047200.36165.B8

[30] Andersen H.R., Knudsen L.L., Hasenkam J.M. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs // European Heart Journal. 1992. Vol. 13, №5. P. 704-708. doi:10.1093/ oxfordjournals.eurheartj.a060238

[31] Paniagua D, Condado JA, Besso J, et al. First human case of retrograde transcatheter implantation of an aortic valve prosthesis. Texas Heart Institute Journal. 2005;32(3):393-8.

[32] Cribier A., Eltchaninoff H., Bash A., et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description // Circulation. 2002. Vol. 106, №24. P. 3006­3008. doi:10.1161/01.CIR.000004 7200.36165.B8

[33] Imaev TE, Komlev AE, Akchurin RS. Transcatheter aortic valve implantation. State of the problem and prospects in Russia. Rational Pharmacotherapy in Cardiology. 2015;11(1):53-9. (In Russ). doi:10.20996/1819-6446-2015-11-1-53-59

[34] Paniagua D., Condado J.A., Besso J., et al. First human case of retrograde transcatheter implantation of an aortic valve prosthesis // Texas Heart Institute Journal. 2005. Vol. 32, №3. P. 393-398.

[35] Belyaev SA, Leont'ev SA, Mohr F-W. Transcatheter aortic valve implantation. Creative Cardiology. 2015;(4):25-33. doi:10.15275/kreatkard.2015.04.03

[36] Имаев Т.Э., Комлев А.Е., Акчурин Р.С. Транс-катетерная имплантация аортального клапана. Состояние проблемы, перспективы в России // Рациональная Фармакотерапия в Кардиологии. 2015. Т. 11, №1. С. 53-59. doi:10.20996/1819-6446-2015-11-1-53-59

[37] Siontis GCM, Overtchouk P, Cahill TJ, et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated metaanalysis. European Heart Journal. 2019;40(38): 3143-53. doi:10.1093/eurheartj/ehz275

[38] Беляев С.А., Леонтьев С.А., Мор Ф.-В. Транскатетерная имплантация аортального клапана // Креативная кардиология. 2015. №4. С. 25-33. doi:10.15275/kreatkard.2015.04.03

[39] Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American Col-lege of Cardiology/American Heart Association task force on clinical practice guidelines. Journal of the American College of Cardiology. 2017;70(2): 252-89. doi:10.1016/j.jacc.2017.03.011

[40] Siontis G.C.M., Overtchouk P., Cahill T.J., et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis // European Heart Journal. 2019. Vol. 40, №38. P. 3143-3153. doi:10.1093/eurheartj/ehz275

[41] Kapadia SR, Leon MB, Makkar RR, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986): 2485-91. doi:10.1016/S0140-6736(15)60290-2

[42] Nishimura R.A., Otto C.M., Bonow R.O., et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines // Journal of the American College of Cardio-logy. 2017. Vol. 70, №2. P. 252-289. doi:10.1016/ j.jacc.2017.03.011

[43] Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. The New England Journal of Medicine. 2011;364(23):2187-98. doi:10.1056/NEJMoa 1103510

[44] Kapadia S.R., Leon M.B., Makkar R.R., et al.

[45] Leon MB, Smith CR, Mack MJ, et al. Transcatheter or Surgical Aortic-Valve Replacement in Inter-mediate-Risk Patients. The New England Journal of Medicine. 2016;374(17):1609-20. doi:10.1056/NEJ Moa1514616

[46] 5-year outcomes of transcatheter aortic valve

[47] Webb JG, Wood DA, Ye J, et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation. 2010;121(16):1848-57. doi:10.1161/CIRCULATIONAHA.109.924613

[48] replacement compared with standard treatment

[49] Thyregod HGH, Ihlemann N, Jørgensen TH, et al. Five-year clinical and echocardiographic outcomes from the Nordic aortic valve intervention (NO-TION) randomized clinical trial in lower surgical risk patients. Circulation. 2019;139(24):2714-23. doi:10.1161/CIRCULATIONAHA.118.036606

[50] for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial // Lancet. 2015. Vol. 385, №9986. P. 2485-2491. doi:10.1016/ S0140-6736(15)60290-2

[51] Margolina AA, Gruzdev KA, Lepilin MG, et al. Complications after transcatheter aortic valve implantation. Kardiologiia. 2016;56(2):35-9. (In Russ). doi:10.18565/ cardio.2016.2.35-39

[52] Smith C.R., Leon M.B., Mack M.J., et al. Trans-catheter versus surgical aortic-valve replacement in high-risk patients // The New England Journal of Medicine. 2011. Vol. 364, №23. P. 2187-2198. doi:10.1056/NEJMoa1103510

[53] Ribeiro HB, Nombela-Franco L, Urena M, et al. Coronary obstruction following transcatheter aortic valve implantation: a systematic review. JACC Cardiovascular Interventions. 2013;6(5):452-61. doi:10.1016/j.jcin.2012.11.014

[54] Leon M.B., Smith C.R., Mack M.J., et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients // The New England Journal of Medicine. 2016. Vol. 374, №17. P. 1609-1620. doi:10.1056/NEJMoa1514616

[55] Webb J.G., Wood D.A., Ye J., et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves // Circulation. 2010. Vol. 121, №16. P. 1848-1857. doi:10.1161/CIRCULATIONAHA. 109.924613

[56] Thyregod H.G.H., Ihlemann N., Jørgensen T.H., et al. Five-year clinical and echocardiographic outcomes from the Nordic aortic valve intervention (NOTION) randomized clinical trial in lower surgical risk patients // Circulation. 2019. Vol. 139, №24. P. 2714-2723. doi:10.1161/CIRCULATIO-NAHA.118.036606

[57] Марголина А.А., Груздев К.А., Лепелин М.Г., и др. Осложнения транскатетерного протезирования аортального клапана // Кардиология. 2016. Т. 56, №2. С. 35-39. doi:10.18565/cardio.2016.2.35-39

[58] Ribeiro H.B., Nombela-Franco L., Urena M., et al. Coronary obstruction following transcatheter aortic valve implantation: a systematic review // JACC Cardiovascular Interventions. 2013. Vol. 6, №5. P. 452-461. doi:10.1016/j.jcin.2012.11.014

RIGHTS & PERMISSIONS

Smirnova E., Terekhina A., Filonenko S., Muranchik E.